Dive into the Boston Scientific $BSX controversy as we break down a securities class action tied to medical devices, electrophysiology growth, and alleged misleading statements around FARAPULSE adoption. This episode is for investors, traders, and anyone following healthcare stocks, medtech innovation, and market risk. Expect deep dives, real case analysis, and insights into competition, slowing procedure volumes, and stock drops.

Visit ZLK.com for more info.

Add our WhatsApp Channel

We’re not lawyers or accountants, so don’t take this as legal or financial advice.